Olema Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Bohen Sean | President and CEO | Gift | 8,500 | — | — | 237,650 | Dec 26, 2025 |
| Harmon Cyrus | — | Sale | 2,881 | $28.53 | $82,195 | 741,259 | Dec 22, 2025 |
| Zojwalla Naseem | Chief Medical Officer | Option Exercise | 7,182 | $7.02 | $50,418 | 153,997 | Dec 22, 2025 |
| CLARK IAN T | — | Sale | 41,840 | $30.48 | $1,275,283 | — | Dec 19, 2025 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 1,225 | $28.08 | $34,398 | 601,656 | Dec 19, 2025 |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Gift | 75,000 | — | — | 243,549 | Dec 8, 2025 |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Gift | 225,000 | — | — | 318,549 | Nov 26, 2025 |
| RAPPAPORT ANDREW | — | Gift | 35,868 | — | — | — | Nov 21, 2025 |
| Harmon Cyrus | — | Sale | 1,914 | $8.08 | $15,465 | 120,114 | Sep 16, 2025 |
| BVF Partners OS Ltd. | — | Disposition | 22,740 | — | — | 347,970 | Jan 10, 2025 |
| Bain Capital Life Sciences Investors, LLC | — | Other | 3,500,000 | — | — | 4,300,000 | Jan 8, 2025 |
| Graham G. Walmsley | — | Sale | 700,761 | $6.75 | $4,730,137 | — | Dec 17, 2024 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Option Exercise | 14,000 | $4.87 | $68,180 | 129,509 | Dec 16, 2024 |
| Graham G. Walmsley | — | Purchase | 700,761 | $6.75 | $4,730,137 | 700,761 | Dec 13, 2024 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Award / Grant | 48,750 | — | — | 624,399 | Dec 11, 2024 |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Sale | 406 | $9.39 | $3,812 | 543,549 | Dec 11, 2024 |
| Harmon Cyrus | — | Sale | 179 | $9.39 | $1,681 | 764,140 | Dec 9, 2024 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Sale | 13,283 | $9.37 | $124,462 | 130,031 | Dec 9, 2024 |
| Bohen Sean | PRESIDENT AND CEO | Sale | 52,328 | $9.37 | $490,313 | 298,836 | Dec 9, 2024 |
| BVF INC/IL | — | Disposition | 153,441 | — | — | 370,710 | Dec 4, 2024 |
| Kovacs Shane William Charles | Ch. Operating & Financial Off. | Option Exercise | 25,000 | $7.02 | $175,500 | 510,458 | Nov 15, 2024 |
| Paradigm Biocapital Advisors LP | — | Sale | 1,870,499 | $14.92 | $27,907,845 | 4,720,482 | Aug 1, 2024 |
| Harmon Cyrus | — | Sale | 934 | $15.55 | $14,524 | 751,283 | Jul 29, 2024 |
| Harmon Cyrus | — | Sale | 5,000 | $12.26 | $61,300 | 756,283 | Jul 11, 2024 |
| Harmon Cyrus | — | Sale | 20,000 | $10.77 | $215,400 | 761,283 | Jun 28, 2024 |
| Graham G. Walmsley | — | Sale | 700,000 | $14.85 | $10,395,000 | 700,761 | Jun 4, 2024 |
| Harmon Cyrus | — | Sale | 5,000 | $10.93 | $54,650 | 786,283 | Jun 4, 2024 |
| Graham G. Walmsley | — | Sale | 700,000 | $14.85 | $10,395,000 | 700,761 | Jun 4, 2024 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Option Exercise | 9,460 | $4.87 | $46,070 | 89,824 | May 24, 2024 |
| Harmon Cyrus | — | Sale | 5,000 | $10.92 | $54,600 | 806,283 | May 6, 2024 |
| Harmon Cyrus | — | Sale | 15,000 | $9.51 | $142,650 | 811,283 | Apr 30, 2024 |
| Harmon Cyrus | — | Sale | 20,000 | $10.97 | $219,400 | 826,283 | Mar 28, 2024 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Option Exercise | 13,700 | $4.87 | $66,719 | 80,364 | Mar 18, 2024 |
| RAPPAPORT ANDREW | — | Other | 481,014 | — | — | — | Mar 5, 2024 |
| Harmon Cyrus | — | Sale | 100 | $13.00 | $1,300 | 846,283 | Feb 29, 2024 |
| Harmon Cyrus | — | Sale | 5,000 | $15.56 | $77,800 | 871,283 | Jan 31, 2024 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Option Exercise | 20,000 | $7.02 | $140,400 | 66,664 | Jan 25, 2024 |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Option Exercise | 50,000 | $7.02 | $351,000 | 484,987 | Jan 12, 2024 |
| Harmon Cyrus | — | Sale | 22,500 | $13.30 | $299,250 | 903,783 | Dec 29, 2023 |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Option Exercise | 10,000 | $7.02 | $70,200 | 434,987 | Dec 12, 2023 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Option Exercise | 2,900 | $7.02 | $20,358 | 46,664 | Dec 11, 2023 |
| Paradigm BioCapital International Fund Ltd. | — | Purchase | 100,000 | $11.60 | $1,160,000 | 6,590,981 | Dec 6, 2023 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Option Exercise | 13,100 | $7.02 | $91,962 | 43,764 | Dec 6, 2023 |
| Graham G. Walmsley | — | Purchase | 508,130 | $9.84 | $4,999,999 | 1,668,130 | Dec 5, 2023 |
| Harmon Cyrus | — | Sale | 25,000 | $12.57 | $314,250 | 926,283 | Nov 30, 2023 |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Sale | 8,897 | $14.83 | $131,943 | 434,832 | Nov 22, 2023 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 6,653 | $13.89 | $92,410 | 574,099 | Nov 21, 2023 |
| Bohen Sean | PRESIDENT AND CEO | Sale | 2,602 | $15.29 | $39,785 | 172,857 | Nov 21, 2023 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Sale | 7,095 | $13.89 | $98,550 | 30,664 | Nov 20, 2023 |
| Harmon Cyrus | — | Sale | 3,989 | $13.90 | $55,447 | 951,283 | Nov 20, 2023 |